As an important product of phenylalanine metabolism of gut microbiota, HA can promote the progression of renal fibrosis by disrupting NRF2-KEAP1-CUL3 to break the redox balance and increase the expression of fibrosis-related genes in CKD (75). Here, KEAP1 is linked to chronic kidney disease.